Baader Bank Aktiengesellschaft’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,500
Closed -$91.7K 452
2023
Q2
$91.7K Buy
+2,500
New +$97.3K ﹤0.01% 351

Other funds holding PFE

Baader Bank Aktiengesellschaft's PFE Position: Q2 2026 in Review

Baader Bank Aktiengesellschaft increased its Pfizer (PFE) stake by 24% in Q2 2026, buying an estimated $285K and bringing the position to 55,904 shares worth $1.35M. The position accounts for 0.1% of the portfolio, ranked #156.

Baader Bank Aktiengesellschaft first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $17M in Q4 2021. 1,698 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Baader Bank Aktiengesellschaft held 55,904 shares of Pfizer worth $1.35M as of Q2 2026.
  • Baader Bank Aktiengesellschaft bought 10,900 Pfizer shares in Q2 2026, an estimated $285K.
  • Pfizer made up 0.1% of Baader Bank Aktiengesellschaft's portfolio in Q2 2026, its #156 holding.
  • Baader Bank Aktiengesellschaft first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • Baader Bank Aktiengesellschaft's Pfizer position peaked at $17M in Q4 2021.
  • 1,698 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2026, filed 23 Jul 2026.